At the American Association of Clinical Chemistry 2023, Erica Blight, VP Client Services, Clinical Research & Marketing at SEKISUI Diagnostics discussed key product highlights and diagnostic testing's evolving landscape with Matthew Raynor, Publisher, Medical Laboratory Observer.
- Acucy®: Features a diagnostic reader and rapid Influenza Flu A & B test.
- SEKURE®: Offers clinical chemistry reagents for various analyzers, addressing lab testing gaps.
- OSOM®: Provides rapid tests for women's health issues like Bacterial Vaginosis, Trichomonas, and respiratory infections including COVID-19 and Flu.
Erica also announced the launch of the OSOM® COVID-19 Antigen Home Test, marking Sekisui Diagnostics’ entry into the home testing market.
Home testing is on the rise, driven by the pandemic. SEKISUI Diagnostics aims to support this trend by hopefully bringing other respiratory tests and some gender health diagnostics to the market in the future.
With SEKISUI Diagnostics innovations, the future of diagnostics looks bright.